A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee

References

• Adler E., Wolf E., Taustein I. A double-blind trial with cartilage and bone marrow extract in degenerative gonarthrosis. Acta Rheum. Scand. 1970; 16: 6111. Adler E., Wolf E., Taustein I. A double-blind trial with cartilage and bone marrow extract in degenerative gonarthrosis. Acta Rheum. Scand. 1970; 16: 611
   Google Scholar
• Annefeld M., Erne B. The mode of action of a glycosaminoglycan-peptide complex (Rumalon®) on articular cartilage of the rat in vivo. Clin. Rheumatol. 1987; 6: 340–3492. Annefeld M., Erne B. The mode of action of a glycosaminoglycan-peptide complex (Rumalon®) on articular cartilage of the rat in vivo. Clin. Rheumatol. 1987; 6: 340–349
   PubMed Web of Science ®Google Scholar
• Bland J. H., Cooper S. M. Osteoarthritis: a review of the cell biology involved and evidence for reversibility, management rationally related to known genesis and patho-physiology. Semin. Arthritis Rheum. 1984; 14: 106–1333. Bland J. H., Cooper S. M. Osteoarthritis: a review of the cell biology involved and evidence for reversibility, management rationally related to known genesis and patho-physiology. Semin. Arthritis Rheum. 1984; 14: 106–133
   PubMed Web of Science ®Google Scholar
• Burkhardt D., Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin. Arthritis Rheum. 1987; 17: 3–34, Suppl. 14. Burkhardt D., Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin. Arthritis Rheum. 1987; 17: 3–34, Suppl. 1
   PubMedGoogle Scholar
• Dieppe P. (1986) Degenerative and crystalline arthritis. “ARA Biennial Review of Rheumatic Disease.” Paper presented at 50th Annual Meeting American Rheumatism Association, New Orleans, June 3, 19865. Dieppe P. (1986) Degenerative and crystalline arthritis. “ARA Biennial Review of Rheumatic Disease.” Paper presented at 50th Annual Meeting American Rheumatism Association, New Orleans, June 3, 1986
   Google Scholar
• Dorn R., Kluge F. Glycosaminoglycan-peptide complex in osteoarthrosis: a long-term trial in general practice. J. Drug Develop 1988, In press6. Dorn R., Kluge F. Glycosaminoglycan-peptide complex in osteoarthrosis: a long-term trial in general practice. J. Drug Develop 1988, In press
   Google Scholar
• Franchimont P. (1987) In vitro assays of chondrocyte functions: possible influence of drugs and hormones in stimulating responses. Paper presented at XIth European Congress of Rheumatology, Athens, July 2, 19877. Franchimont P. (1987) In vitro assays of chondrocyte functions: possible influence of drugs and hormones in stimulating responses. Paper presented at XIth European Congress of Rheumatology, Athens, July 2, 1987
   Google Scholar
• Kalbhen D. A. Experimental pharmacological study on the antiarthrotic effect of the cartilage-bone marrow extract Rumalon.®. Therapiewoche 1981; 31: 4983–50018. Kalbhen D. A. Experimental pharmacological study on the antiarthrotic effect of the cartilage-bone marrow extract Rumalon.®. Therapiewoche 1981; 31: 4983–5001
   Google Scholar
• Katona G. A clinical trial of glycosaminoglycan-peptide complex (‘Rumalon’) in patients with osteoarthritis of the knee. Curr. Med. Res. Opin. 1987; 10: 625–6339. Katona G. A clinical trial of glycosaminoglycan-peptide complex (‘Rumalon’) in patients with osteoarthritis of the knee. Curr. Med. Res. Opin. 1987; 10: 625–633
   PubMed Web of Science ®Google Scholar
• Loyau G. Effet du Rumalon sur le métabolisme des protéoglycanes des chondro-cytes articulaires soumis à l'action de l'interleukine-1. Caen, France 1986, 1986 (unpublished)10. Loyau G. Effet du Rumalon sur le métabolisme des protéoglycanes des chondro-cytes articulaires soumis à l'action de l'interleukine-1. Caen, France 1986, 1986 (unpublished)
   Google Scholar
• Mazières B., Hérou P., Dambreville J. M., Thiéchart M. Die Wirkung eines Glykosaminoglykan-Peptid-Komplexes (GAG-Peptid-Komplex) bei experimenteller Arthrose am Kaninchen. Aktuel. Rheumatol. 1984; 9: 133–138, (Sonderheft)11. Mazières B., Hérou P., Dambreville J. M., Thiéchart M. Die Wirkung eines Glykosaminoglykan-Peptid-Komplexes (GAG-Peptid-Komplex) bei experimenteller Arthrose am Kaninchen. Aktuel. Rheumatol. 1984; 9: 133–138, (Sonderheft)
   Web of Science ®Google Scholar
• Moskowitz R. W. Osteoarthritis: studies with experimental models. Arthritis Rheum 1977; 20: 104, Suppl. 612. Moskowitz R. W. Osteoarthritis: studies with experimental models. Arthritis Rheum 1977; 20: 104, Suppl. 6
   Google Scholar
• Newton Ch. D., Fetter A., Bashey R. I., Jimenez S. A. Clinical studies and pathological changes in articular cartilage in experimental canine osteoarthrosis and effects of the in vivo administration of a glycosaminoglycanpeptide (GAG-Peptide-complex) from bone marrow and cartilage. Aktuel. Rheumatol. 1984; 9: 128–133, (Sonderheft)13. Newton Ch. D., Fetter A., Bashey R. I., Jimenez S. A. Clinical studies and pathological changes in articular cartilage in experimental canine osteoarthrosis and effects of the in vivo administration of a glycosaminoglycanpeptide (GAG-Peptide-complex) from bone marrow and cartilage. Aktuel. Rheumatol. 1984; 9: 128–133, (Sonderheft)
   Web of Science ®Google Scholar
• Rao V. H., Brighton C. T., Jimenez S. A. (1987) Inhibition of proteoglycan degradation in rabbit articular cartilage organ cultures by a glycosaminoglycan peptide (GAG-pep) from cartilage and bone marrow. Paper presented at 33rd Orthopaedic Research Society Meeting, San Francisco, 17 January, 198714. Rao V. H., Brighton C. T., Jimenez S. A. (1987) Inhibition of proteoglycan degradation in rabbit articular cartilage organ cultures by a glycosaminoglycan peptide (GAG-pep) from cartilage and bone marrow. Paper presented at 33rd Orthopaedic Research Society Meeting, San Francisco, 17 January, 1987
   Google Scholar
• Rejholec V. Long-term studies of antiosteoarthritic drugs: an assessment. Semin. Arthritis Rheum. 1987; 17: 35–53, Suppl. 115. Rejholec V. Long-term studies of antiosteoarthritic drugs: an assessment. Semin. Arthritis Rheum. 1987; 17: 35–53, Suppl. 1
   PubMedGoogle Scholar